General Information of Drug (ID: DMEXW31)

Drug Name
NSC-663284 Drug Info
Synonyms
NSC 663284; 383907-43-5; NSC-663284; NSC663284; CDC25 Phosphatase Inhibitor II, NSC 663284; 6-Chloro-7-(2-morpholin-4-yl-ethylamino)quinoline-5,8-dione; 6-chloro-7-{[2-(morpholin-4-yl)ethyl]amino}quinoline-5,8-dione; DA3003-1; 6-Chloro-7-((2-morpholinoethyl)amino)quinoline-5,8-dione; AC1Q3HBF; AC1Q3HBE; SPS8I1; MLS006010693; SCHEMBL2556224; AC1L8E02; CTK4H9880; CHEBI:92053; DTXSID50327512; MolPort-003-983-788; HMS3268K22; BCP16027; MFCD08276924; BS0130; ZINC100002044; AKOS024456823; CS-7519; NCGC00092289-01; NCGC00092289-02
Cross-matching ID
PubChem CID
379077
ChEBI ID
CHEMBL337173
CAS Number
CAS 383907-43-5
TTD Drug ID
D0XU7M

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Legionellosis 2.30 0.00e+0 51/57 (89.47%) CXCL8;HSPA6;HSPA1A;...
IL-17 signaling pathway 2.29 0.00e+0 84/94 (89.36%) CXCL8;FOSL1;FOSB;...
Rheumatoid arthritis 2.20 3.97e-3 78/93 (83.87%) CXCL8;FOS;JUN;...
TNF signaling pathway 2.13 5.95e-3 103/112 (91.96%) FOS;JUN;TNFAIP3;...
NF-kappa B signaling pathway 1.97 1.19e-2 90/104 (86.54%) CXCL8;GADD45B;GADD45A;...
Fluid shear stress and atherosclerosis 1.92 9.92e-3 123/139 (88.49%) HMOX1;FOS;JUN;...
Lipid and atherosclerosis 1.85 1.87e-2 190/215 (88.37%) CXCL8;HSPA6;FOS;...
Mitophagy 1.70 4.94e-2 56/68 (82.35%) JUN;SQSTM1;ATF4;...
Bladder cancer 1.69 4.93e-2 40/41 (97.56%) CXCL8;CDKN1A;HBEGF;...
Fructose and mannose metabolism 1.69 4.68e-2 30/33 (90.91%) PFKFB3;AKR1B1;PFKP;...
Protein processing in endoplasmic reticulum 1.68 4.46e-2 127/171 (74.27%) HSPA6;PPP1R15A;HSPA1A;...
Amphetamine addiction 1.67 4.48e-2 57/69 (82.61%) FOSB;FOS;JUN;...
HIF-1 signaling pathway 1.67 4.30e-2 105/109 (96.33%) HMOX1;CDKN1A;VEGFA;...
Spliceosome 1.66 4.89e-2 101/150 (67.33%) HSPA6;HSPA1A;HNRNPA1;...
Viral protein interaction with cytokine and cytokine re... 1.66 4.64e-2 84/100 (84%) CXCL8;CXCL14;IL6;...
Colorectal cancer 1.65 4.53e-2 84/86 (97.67%) GADD45B;FOS;CDKN1A;...
Kaposi sarcoma-associated herpesvirus infection 1.65 4.33e-2 172/193 (89.12%) CXCL8;FOS;CDKN1A;...
Peroxisome -2.06 0.00e+0 72/82 (87.8%) PEX16;PEX7;DDO;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 2.5uM - 10uM 6H, 24H
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 2.5uM - 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H